Lee's Pharmaceutical Holdings Limited
Research Lee's Pharmaceutical Holdings Limited (0950.HK) on Bullrun: market cap HKD 635.94M, P/E 6.8, dividend yield 4.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0950.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 635.94M
- P/E6.8
- Dividend yield4.2%
- Financial periodFY2025
- RevenueHKD 1.44B
- Revenue growth2.6%
- Net incomeHKD 91.94M
- Free cash flowHKD 101.35M
- Gross margin50.8%
Valuation Snapshot
latest market cap is HKD 635.94M; P/E is 6.8; dividend yield is 4.2%.
Peer valuation comparison
Latest P/E is 6.75x versus a Healthcare sector median of 23.83x (71.7% below).
Latest dividend yield is 4.17% versus a Healthcare sector median of 2.18% (91.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 1.44B | HKD 91.94M | HKD 101.35M | 50.8% | 0.16 | HKD 349.90M | HKD 310.27M | HKD 2.05B |
| FY2024 | HKD 1.40B | HKD 93.10M | HKD 34.45M | 53.8% | 0.16 | HKD 216.85M | HKD 227.30M | HKD 1.65B |
| FY2023 | HKD 1.05B | HKD 16.70M | -HKD 49.63M | 52.4% | 0.03 | HKD 171.00M | HKD 204.14M | HKD 2.04B |
| FY2022 | HKD 1.23B | HKD 51.28M | HKD 69.81M | 62.5% | 0.09 | HKD 189.30M | HKD 163.49M | HKD 1.92B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-04 | HKD 635.94M | 6.8 | 4.3% | 0.05 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.05 HKD, yield 4.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.05 HKD |
| FY2024 | 0.03 HKD |
| FY2023 | 0.02 HKD |
| FY2022 | 0.04 HKD |
| FY2021 | 0.06 HKD |
About Lee's Pharmaceutical Holdings Limited
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lee's Pharmaceutical Holdings Limited's market cap?
Lee's Pharmaceutical Holdings Limited's market capitalization is HKD 635.94M.
What is Lee's Pharmaceutical Holdings Limited's P/E ratio?
Lee's Pharmaceutical Holdings Limited's price-to-earnings (P/E) ratio is 6.8.
Does Lee's Pharmaceutical Holdings Limited pay a dividend?
Lee's Pharmaceutical Holdings Limited has a dividend yield of 4.2%.
What does Lee's Pharmaceutical Holdings Limited do?
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments.